Evidence map›Paper›PMID 30396911›Full record

ArticleBlood advances2018

Persistence of endothelial thrombomodulin in a patient with infectious purpura fulminans treated with protein C concentrate.

Pavan K Bendapudi, Alissa Robbins, Nicole LeBoeuf, Olga Pozdnyakova, Ami Bhatt, Fujiko Duke, Ryan Sells, John McQuiston, Ben Humrighouse, Betty Rouaisnel and 4 more

Abstract readCase Reports
In one paragraph

Article in Blood advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Critical bloodstream infection caused byFrontiers in medicine · 2024
    Article
  4. Article
  5. Purpura fulminans secondary toAccess microbiology · 2023
    Article
  6. Thrombosis questions from the inpatient wards.Hematology. American Society of Hematology. Education Program · 2022
    Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Pavan K BendapudiDivision of Hematology and Blood Transfusion Service, Massachusetts General Hospital, Boston, MA.
Alissa RobbinsDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Nicole LeBoeufHarvard Medical School, Boston, MA.
Olga PozdnyakovaHarvard Medical School, Boston, MA.
Ami BhattHematology and Bone Marrow Transplantation Unit, Department of Medicine, and.
Fujiko DukeDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Ryan SellsHarvard Medical School, Boston, MA.
John McQuistonCenters for Disease Control and Prevention, Atlanta, GA.
Ben HumrighouseCenters for Disease Control and Prevention, Atlanta, GA.
Betty RouaisnelDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Meaghan CollingDivision of Hematology and Blood Transfusion Service, Massachusetts General Hospital, Boston, MA.
Kathryn E StephensonHarvard Medical School, Boston, MA.
Arturo SaavedraDepartment of Dermatology, University of Virginia Health System, Charlottesville, VA.
Julie-Aurore LosmanHarvard Medical School, Boston, MA.

Funding

The Role of Coagulation Factor XII in Hemostasis and ThrombosisK08HL136840 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BENDAPUDI, PAVAN · 2017 to 2021
$817k
NHLBI NIH HHS K08 HL136840
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAnticoagulantsCapnocytophagaEndotheliumE-SelectinHumansMaleProtein CPurpura FulminansRNA, Ribosomal, 16SThrombomodulinAnticoagulantsE-SelectinProtein CRNA, Ribosomal, 16SThrombomodulin

Identifiers

PMID30396911
PMCPMC6234356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.